2-((5-(4-(叔丁氧基羰基)哌嗪-1-基)吡啶-2-基)氨基)-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸乙酯

更新时间:2024-01-30 19:29:03

2-((5-(4-(叔丁氧基羰基)哌嗪-1-基)吡啶-2-基)氨基)-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸乙酯结构式
2-((5-(4-(叔丁氧基羰基)哌嗪-1-基)吡啶-2-基)氨基)-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸乙酯结构式
品牌特惠专场
常用名 2-((5-(4-(叔丁氧基羰基)哌嗪-1-基)吡啶-2-基)氨基)-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸乙酯 英文名 ETHYL 2-((5-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)PYRIDIN-2-YL)AMINO)-8-CYCLOPENTYL-5-METHYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE
CAS号 571189-03-2 分子量 577.67500
密度 N/A 沸点 N/A
分子式 C30H39N7O5 熔点 N/A
MSDS N/A 闪点 N/A

 名称

中文名 2-((5-(4-(叔丁氧基羰基)哌嗪-1-基)吡啶-2-基)氨基)-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸乙酯
英文名 ethyl 8-cyclopentyl-5-methyl-2-[[5-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridin-2-yl]amino]-7-oxopyrido[2,3-d]pyrimidine-6-carboxylate

 物理化学性质

分子式 C30H39N7O5
分子量 577.67500
精确质量 577.30100
PSA 131.78000
LogP 4.66330

 合成线路

~29%

2-((5-(4-(叔丁氧基羰基)哌嗪-1-基)吡啶-2-基)氨基)-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸乙酯结构式

2-((5-(4-(叔丁氧基羰...

571189-03-2

文献:Barvian, Mark; Booth, Richard John; Ouin III, John; Thomas Repine, Joseph; Sheehan, Derek J.; Toogood, Peter Laurence; Vanderwel, Scott Norman; Zhou, Hairong Patent: US2003/149001 A1, 2003 ; US 20030149001 A1

~%

2-((5-(4-(叔丁氧基羰基)哌嗪-1-基)吡啶-2-基)氨基)-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸乙酯结构式

2-((5-(4-(叔丁氧基羰...

571189-03-2

文献:Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W. Journal of Medicinal Chemistry, 2005 , vol. 48, # 7 p. 2388 - 2406

~%

2-((5-(4-(叔丁氧基羰基)哌嗪-1-基)吡啶-2-基)氨基)-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸乙酯结构式

2-((5-(4-(叔丁氧基羰...

571189-03-2

文献:Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W. Journal of Medicinal Chemistry, 2005 , vol. 48, # 7 p. 2388 - 2406

~%

2-((5-(4-(叔丁氧基羰基)哌嗪-1-基)吡啶-2-基)氨基)-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸乙酯结构式

2-((5-(4-(叔丁氧基羰...

571189-03-2

文献:Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W. Journal of Medicinal Chemistry, 2005 , vol. 48, # 7 p. 2388 - 2406

~%

2-((5-(4-(叔丁氧基羰基)哌嗪-1-基)吡啶-2-基)氨基)-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸乙酯结构式

2-((5-(4-(叔丁氧基羰...

571189-03-2

文献:Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W. Journal of Medicinal Chemistry, 2005 , vol. 48, # 7 p. 2388 - 2406

~%

2-((5-(4-(叔丁氧基羰基)哌嗪-1-基)吡啶-2-基)氨基)-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸乙酯结构式

2-((5-(4-(叔丁氧基羰...

571189-03-2

文献:Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W. Journal of Medicinal Chemistry, 2005 , vol. 48, # 7 p. 2388 - 2406